Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Equity Ratio (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Equity Ratio for 3 consecutive years, with 0.05 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 92.62% to 0.05 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05 through Dec 2025, down 92.62% year-over-year, with the annual reading at 0.05 for FY2025, 92.62% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.05 at Inhibrx Biosciences, down from 0.21 in the prior quarter.
  • The five-year high for Equity Ratio was 0.85 in Q2 2024, with the low at 0.05 in Q4 2025.
  • Average Equity Ratio over 3 years is 0.44, with a median of 0.36 recorded in 2025.
  • The sharpest move saw Equity Ratio surged 423.02% in 2024, then tumbled 92.62% in 2025.
  • Over 3 years, Equity Ratio stood at 0.14 in 2023, then soared by 423.02% to 0.74 in 2024, then crashed by 92.62% to 0.05 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.05, 0.21, and 0.32 for Q4 2025, Q3 2025, and Q2 2025 respectively.